trans-2-(2-(Trifluoromethyl)phenyl)cyclopropanamine hydrochloride, 95.0%, 1g

4,6-Dichloro-2-cyclohexylpyrimidine, 1g

Ethyl N-(mesitylsulfonyl)oxyacetimidate, 95.0%, 5g

3-Bromomethyl-pyrrolidine-1-carboxylic acid benzyl ester, 95.0%, 100mg

(S)-tert-Butyl 2-amino-2-phenylacetate hydrochloride, 95.0%, 10g

Polvo de manganeso, bajo contenido de oxígeno 99,8+% 125-500 micrones 100 g

1-Methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 95.0%, 5g

Ethyl 4-chloro-6-methylpyrimidine-5-carboxylate, 95.0%, 5g

4,4,4',4',6,6,6',6'-Octamethyl-2,2'-bi(1,3,2-dioxaborinane), 95.0%, 5g

1-(4-Fluorophenyl)-2-pyrrolidinone, 95.0%, 10g

Elvitegravir, 98.0%, 100mg

6-Bromoimidazo[1,2-a]pyridin-2-amine, 97.0%, 250mg

6-Bromoisoquinoline-1-carbonitrile, 95.0%, 250mg